Supplementary Tables from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers

Authors :: David M. Hyman
Michael C. Wei
Timothy R. Wilson
Maurizio Scaltriti
Heidi M. Savage
Surai Jones
John Bond
Helen Won
Lara Dunn
Jasgit C. Sachdev
Philippe L. Bedard
Raid Aljumaily
Cynthia X. Ma
Vincent Ribrag
Manish R. Patel
Anton Melnyk
Valentina Gambardella
Cristina Saura
Dejan Juric
Matthew T. Chang
Komal Jhaveri
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Tables

Full Text Access

Tools